(Q40923073)

24 September 2017

1 reference

title

Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). (English)

1 reference

24 September 2017

B H Wolffenbuttel

1

1 reference

24 September 2017

T W van Haeften

series ordinal

2

1 reference

24 September 2017

publication date

1 August 1995

1 reference

24 September 2017

1 reference

24 September 2017

volume

50

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

263-288

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199550020-00006

24 September 2017

exact match

0 references

cites work

Microalbuminuria. Implications for micro- and macrovascular disease

1 reference

12 December 2020

The sulphonylurea receptor may be an ATP-sensitive potassium channel.

1 reference

12 December 2020

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

1 reference

12 December 2020

Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas.

1 reference

12 December 2020

The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five year follow-up study

1 reference

12 December 2020

Retinopathy in older type II diabetics. Association with glucose control

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)

1 reference

12 December 2020

Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs

1 reference

12 December 2020

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

Metformin Causes a Reduction in Basal and Post-venous Occlusion Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients

1 reference

12 December 2020

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

12 December 2020

Direct effects of biguanides on glucose utilization in vitro

1 reference

12 December 2020

Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics.

1 reference

12 December 2020

The aldose reductase controversy

1 reference

12 December 2020

Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.

1 reference

12 December 2020

The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes

1 reference

12 December 2020

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

1 reference

12 December 2020

Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses.

1 reference

12 December 2020

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

1 reference

12 December 2020

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

1 reference

12 December 2020

Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.

1 reference

12 December 2020

Farewell to phenformin for treating diabetes mellitus

1 reference

12 December 2020

Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition.

1 reference

12 December 2020

The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis

1 reference

12 December 2020

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

12 December 2020

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications

1 reference

12 December 2020

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

12 December 2020

Drug-induced reversal of early diabetic microangiopathy

1 reference

12 December 2020

Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.

1 reference

12 December 2020

Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment

1 reference

12 December 2020

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil

1 reference

12 December 2020

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Role of advanced glycosylation products in complications of diabetes.

1 reference

12 December 2020

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

1 reference

12 December 2020

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Clinical biostatistics. XXXV. The persistent clinical failures and fallacies of the UGDP study

1 reference

12 December 2020

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

1 reference

12 December 2020

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

1 reference

12 December 2020

Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus

1 reference

12 December 2020

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

1 reference

12 December 2020

Long-term complications of diabetes mellitus

1 reference

12 December 2020

Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

Association in vivo of glycated apolipoprotein A-I with high density lipoproteins

1 reference

12 December 2020

Quantitative histochemistry of the sorbitol pathway in glomeruli and small arteries of human diabetic kidney

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (2nd part) (author's transl)

1 reference

12 December 2020

Laminin alterations after in vitro nonenzymatic glycosylation

1 reference

12 December 2020

The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.

1 reference

12 December 2020

"Settling the UGDP Controversy"?

1 reference

12 December 2020

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes

1 reference

12 December 2020

Action of Sorbinil in Diabetic Peripheral Nerve: Relationship of Polyol (Sorbitol) Pathway Inhibition to a myo-Inositol-mediated Defect in Sodium-Potassium ATPase Activity

1 reference

12 December 2020

U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study

1 reference

12 December 2020

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

1 reference

12 December 2020

Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil

1 reference

12 December 2020

Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease

1 reference

12 December 2020

Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes

1 reference

12 December 2020

Is insulin atherogenic?

1 reference

12 December 2020

Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase

1 reference

12 December 2020

Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

12 December 2020

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

MEASUREMENT OF GLUCOSE DISPOSAL RATES IN NORMAL AND DIABETIC HUMAN SUBJECTS AFTER REPEATED INTRAVENOUS INJECTIONS OF GLUCOSE

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Kinetics of glucose disposal in whole body and across the forearm in man.

1 reference

12 December 2020

Correlation of serum lipids with diabetes control in sulfonylurea-treated diabetic patients.

1 reference

12 December 2020

Postprandial lipemia, fenofibrate and coronary artery disease

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-rat

1 reference

12 December 2020

Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats

1 reference

12 December 2020

Long term improvement in insulin response with gliclazide treatment

1 reference

12 December 2020

1 reference

12 December 2020

The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).

1 reference

12 December 2020

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

12 December 2020

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation

1 reference

12 December 2020

Role of oxidised low density lipoprotein in atherogenesis

1 reference

12 December 2020

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

12 December 2020

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

12 December 2020

Insulin secretion as studied on isolated perfused rat pancreas. I. Synergism between glucose and hypoglycaemic sulphonamides

1 reference

12 December 2020

Recent progress on the biologic and clinical significance of advanced glycosylation end products

1 reference

12 December 2020

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

12 December 2020

Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat

1 reference

12 December 2020

Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure.

1 reference

12 December 2020

Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine

1 reference

12 December 2020

Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy

1 reference

12 December 2020

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

12 December 2020

Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?

1 reference

12 December 2020

Increased serum conjugated dienes in elderly diabetic patients

1 reference

12 December 2020

Plasma malondialdehyde in type 1 and type 2 diabetic patients.

1 reference

12 December 2020

Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics

1 reference

12 December 2020

Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics

1 reference

12 December 2020

Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats

1 reference

12 December 2020

Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.

1 reference

12 December 2020

Diabetic retinopathy in non-insulin-dependent diabetes mellitus patients: the role of gliclazide

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)

1 reference

12 December 2020

1 reference

12 December 2020

Effects of tolbutamide on gluconeogenesis and glycolysis in isolated perfused rat liver

1 reference

12 December 2020

Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Pravastatin, lipids, and major coronary events

1 reference

12 December 2020

Diabetic nephropathy. An update

1 reference

12 December 2020

The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients

1 reference

12 December 2020

Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues

1 reference

12 December 2020

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus

1 reference

12 December 2020

The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus

1 reference

12 December 2020

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

12 December 2020

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

12 December 2020

Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus

1 reference

12 December 2020

Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?

1 reference

12 December 2020

Sulfonylureas activate glycogen phosphorylase and increase cytosolic free-Ca2+ levels in isolated rat hepatocytes

1 reference

12 December 2020

Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk

1 reference

12 December 2020

Atherosclerosis in diabetes: the role of hyperinsulinemia

1 reference

12 December 2020

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

1 reference

12 December 2020

Diabetic dyslipidemia

1 reference

12 December 2020

Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes

1 reference

12 December 2020

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

12 December 2020

Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects

1 reference

12 December 2020

Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study

1 reference

12 December 2020

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

12 December 2020

A comparative study of sulphonylurea and insulin therapy in non insulin dependent diabetics who had failed on diet therapy alone

1 reference

12 December 2020

Treatment of type 2 (non-insulin-dependent) diabetic patients with diet alone.

1 reference

12 December 2020

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

1 reference

12 December 2020

A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors

1 reference

12 December 2020

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients

1 reference

12 December 2020

Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets

1 reference

12 December 2020

Metformin action on lipid metabolism in lesions of experimental aortic atherosclerosis of rabbits

1 reference

12 December 2020

A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group

1 reference

12 December 2020

Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

1 reference

12 December 2020

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

1 reference

12 December 2020

Immune mechanisms of atherosclerosis in diabetes mellitus

1 reference

12 December 2020

Improvement of glucose-primed intravenous glucose tolerance and correction of acute insulin decrement by glipizide in type II diabetes.

1 reference

12 December 2020

Capillary number and percentage closed in human diabetic sural nerve

1 reference

12 December 2020

alpha-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects.

1 reference

12 December 2020

Abnormal lipoprotein composition in normolipidemic diabetic patients

1 reference

12 December 2020

Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes

1 reference

12 December 2020

Insulin and atheroma. 20-yr perspective

1 reference

12 December 2020

Non-insulin dependent diabetes mellitus: defects in insulin secretion

1 reference

12 December 2020

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

12 December 2020

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

12 December 2020

The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.

1 reference

12 December 2020

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

An evaluation of long-term glycemic control in non-insulin-dependent diabetes mellitus: the relevance of glycated hemoglobin.

1 reference

12 December 2020

Identification of multiple subclasses of plasma low density lipoproteins in normal humans

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

12 December 2020

Ernst Klenk Lecture, November 1985. Intracellular signalling through inositol trisphosphate and diacylglycerol

1 reference

12 December 2020

Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.

1 reference

12 December 2020

Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study

1 reference

12 December 2020

Glycation products and the pathogenesis of diabetic complications

1 reference

12 December 2020

Non-insulin-dependent diabetes in older patients. Complications and risk factors

1 reference

12 December 2020

Problems and pitfalls of sulphonylurea therapy in older patients

1 reference

12 December 2020

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

12 December 2020

Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer

1 reference

12 December 2020

Epidemiology of proliferative diabetic retinopathy

1 reference

12 December 2020

Lp(a) concentrations in NIDDM

1 reference

12 December 2020

Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations

1 reference

12 December 2020

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

12 December 2020

High-density lipoprotein subclasses in diabetes

1 reference

12 December 2020

Increased diene conjugates in diabetic subjects with microangiopathy

1 reference

12 December 2020

The changing natural history of nephropathy in type I diabetes

1 reference

12 December 2020

A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.

1 reference

12 December 2020

Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.

1 reference

12 December 2020

Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

12 December 2020

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

12 December 2020

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

[Value of gliclazide in the treatment of early diabetic retinopathy]

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Glucose control and the renal and retinal complications of insulin-dependent diabetes

1 reference

12 December 2020

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

1 reference

12 December 2020

Increased lipid peroxidation in type 2 poorly controlled diabetic patients

1 reference

12 December 2020

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

1 reference

12 December 2020

Insulin Receptor Binding to Monocytes, Insulin Secretion, and Glucose Tolerance Following Metformin Treatment: Results of a Double-Blind Cross-Over Study in Type II Diabetics

1 reference

12 December 2020

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

1 reference

12 December 2020

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

1 reference

12 December 2020

Diabetic hypertriglyceridemia: evidence for three clinical syndromes

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats

1 reference

12 December 2020

Insulin treatment improves microalbuminuria and other cardiovascular risk factors in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Systolic blood pressure as a predictor for cardiovascular disease in diabetes. A 5-year longitudinal study

1 reference

12 December 2020

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

1 reference

12 December 2020

Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance

1 reference

12 December 2020

Sites of metformin-stimulated glucose metabolism

1 reference

12 December 2020

Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas

1 reference

12 December 2020

Preventive effect of gliclazide on experimental atherosclerosis in rabbits

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Alpha-glucosidase inhibition prevents increased collagen fluorescence in experimental diabetes

1 reference

12 December 2020

Relation of Lipid Peroxides to Macrovascular Disease in Type 2 Diabetes

1 reference

12 December 2020

Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.

1 reference

12 December 2020

Controversy Over Study of Diabetes Drugs Continues for Nearly a Decade

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

Lipids, diabetes, and vascular disease: the time to act.

1 reference

12 December 2020

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

1 reference

12 December 2020

Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.

1 reference

12 December 2020

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

1 reference

12 December 2020

Lipoprotein lipase in diabetes

1 reference

12 December 2020

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide

1 reference

12 December 2020

Lipoprotein glycation and its metabolic consequences

1 reference

12 December 2020

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats

1 reference

12 December 2020

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

12 December 2020

Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats

1 reference

12 December 2020

Hyperglycemic pseudohypoxia and diabetic complications.

1 reference

12 December 2020

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

1 reference

12 December 2020

Audit confirms conclusions of UGDP study on oral diabetes drugs

1 reference

12 December 2020

Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study

1 reference

12 December 2020

Acarbose and insulin therapy in type I diabetes mellitus

1 reference

12 December 2020

Aldose reductase activity in retinal and cerebral microvessels and cultured vascular cells.

1 reference

12 December 2020

Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy

1 reference

12 December 2020

Paradoxical Inhibition of Insulin Secretion by Glucose in Human Diabetes Mellitus*

1 reference

12 December 2020

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

1 reference

12 December 2020

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

1 reference

12 December 2020

Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation

1 reference

12 December 2020

The Achilles heel of the University Group Diabetes Program

1 reference

12 December 2020

Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.

1 reference

12 December 2020

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

10.2165/00003495-199550020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1001169061

0 references

1 reference